What is the treatment for ringworm (tinea infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Ringworm (Tinea Infection)

For localized tinea corporis or tinea cruris, apply topical terbinafine 1% cream twice daily for 1-2 weeks, which provides superior efficacy compared to other topical agents and requires shorter treatment duration. 1, 2

Topical Therapy for Limited Skin Infections

First-Line Topical Treatment

  • Terbinafine 1% cream applied twice daily for 1 week achieves 93.5% mycological cure rates, significantly superior to clotrimazole's 73.1% cure rate after 4 weeks of treatment 1
  • Allylamines (terbinafine, naftifine) require only 1-2 weeks of treatment compared to 2-4 weeks for azoles 3, 2
  • Naftifine 1% cream is also highly effective with a number needed to treat (NNT) of 3 for both mycological and clinical cure 2

Alternative Topical Agents

  • Azole creams (clotrimazole, miconazole) applied twice daily for 2-4 weeks are effective but require longer treatment duration 3, 2
  • Butenafine cream is another effective option for tinea corporis and cruris 4
  • Continue treatment for at least 1 week after clinical clearing to prevent relapse 3

Important Caveat on Topical Steroids

  • Combination antifungal/steroid creams show higher clinical cure rates at end of treatment but are NOT recommended in clinical guidelines due to potential for skin atrophy and other steroid complications 2
  • Use combination products with extreme caution and only for severe inflammation 3

Oral Therapy Indications

When to Use Systemic Treatment

Oral antifungals are required for:

  • Tinea capitis (scalp ringworm) - topical therapy alone is inadequate 5
  • Extensive skin involvement not responding to topical therapy 6, 7
  • Tinea unguium (nail infections) 7
  • Failed topical treatment 4
  • Immunocompromised patients 4

Oral Treatment Options for Tinea Corporis/Cruris

Terbinafine (preferred):

  • 250 mg daily for 1-2 weeks, particularly effective against Trichophyton tonsurans 6, 8
  • Shorter treatment duration compared to other agents 8

Itraconazole:

  • 100 mg daily for 2 weeks OR 200 mg daily for 7 days 8
  • 87% mycological cure rate for tinea corporis 6
  • Important drug interactions: enhanced toxicity with warfarin, certain antihistamines (terfenadine, astemizole), antipsychotics, midazolam, digoxin, cisapride, and simvastatin 5, 6

Fluconazole (third-line):

  • 50-100 mg daily for 2-3 weeks OR 150 mg once weekly for 2-3 weeks 8
  • Less cost-effective than terbinafine with limited comparative data 6

Tinea Capitis Treatment Protocol

First-Line Systemic Therapy

Treatment selection depends on the causative organism - local epidemiology should guide initial choice 5:

For Trichophyton species (most common in UK/US):

  • Terbinafine is superior:
    • <20 kg: 62.5 mg daily for 2-4 weeks
    • 20-40 kg: 125 mg daily for 2-4 weeks
    • 40 kg: 250 mg daily for 2-4 weeks 5

For Microsporum species:

  • Griseofulvin remains treatment of choice:
    • 20-25 mg/kg daily for 6-8 weeks if <50 kg
    • 1 g daily for 6-8 weeks if >50 kg 5, 7
    • Take with fatty food to improve absorption 5

Adjunctive Topical Therapy

  • Use antifungal shampoos (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission, though they cannot cure the infection alone 5
  • Apply 2-3 times weekly throughout treatment 5

Critical Management Points

  • Start treatment immediately if kerion is present or diagnosis is clinically certain - do not wait for culture results 5
  • The endpoint is mycological cure, not clinical improvement - continue follow-up with monthly cultures until clearance is documented 5
  • Children can return to school once appropriate systemic therapy is started 5

Treatment Failure Management

Second-Line Therapy

If no clinical improvement after initial treatment:

  • Switch from terbinafine to griseofulvin for Microsporum infections 5
  • Switch from griseofulvin to terbinafine for Trichophyton infections 5
  • Itraconazole 50-100 mg daily for 4 weeks OR 5 mg/kg daily for 2-4 weeks is effective for both Trichophyton and Microsporum species 5

If clinical improvement but persistent positive cultures:

  • Continue current therapy for additional 2-4 weeks 5

Refractory Cases

  • Consider fluconazole or voriconazole in exceptional circumstances 5
  • Voriconazole is more potent but limited by cost and availability 5

Prevention and Screening

Essential Preventive Measures

  • Screen and treat all family members and close contacts for Trichophyton tonsurans infections - over 50% may be affected 5, 6
  • Clean contaminated combs, brushes, and towels with disinfectant or 2% sodium hypochlorite solution 5, 6
  • Avoid skin-to-skin contact with infected individuals 6
  • Do not share personal items (towels, clothing, sports equipment) 6
  • Cover lesions during treatment 6

Asymptomatic Carriers

  • Treat asymptomatic carriers with high spore loads using systemic antifungals to prevent transmission 5

Common Pitfalls to Avoid

  • Do not diagnose tinea infections on clinical appearance alone - confirm with potassium hydroxide preparation or culture, especially for onychomycosis and tinea capitis 4
  • Do not use topical therapy alone for tinea capitis - it will fail 5
  • Do not stop treatment when lesions clear clinically - continue until mycological cure is achieved 5, 7
  • Do not use griseofulvin as first-line for Trichophyton infections - terbinafine is superior 6
  • Avoid combination steroid/antifungal creams except in severe inflammation due to risk of skin atrophy 3, 2

References

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Diagnosis and management of tinea infections.

American family physician, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.